Celularity Inc (CELUW)

CELUW was delisted on the 17th of July, 2026.

• Market cap: $27.3K
• Sector: Healthcare
• Industry: Biotechnology

About: Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Employees: 115